A randomized multicenter phase III study comparing weekly versus every 3 weeks carboplatin (C) plus paclitaxel (P) in patients with advanced ovarian cancer (AOC): Multicenter Italian Trials in Ovarian Cancer (MITO-7)—European Network of Gynaecological Oncological Trial Groups (ENGOT-ov-10) and Gynecologic Cancer Intergroup (GCIG) trial.
Sandro Pignata
No relevant relationships to disclose
Giovanni Scambia
No relevant relationships to disclose
Rossella Lauria
No relevant relationships to disclose
Francesco Raspagliesi
No relevant relationships to disclose
Pierluigi Benedetti Panici
No relevant relationships to disclose
Gennaro Cormio
No relevant relationships to disclose
Dionyssios Katsaros
No relevant relationships to disclose
Roberto Sorio
No relevant relationships to disclose
Giovanna Cavazzini
No relevant relationships to disclose
Gabriella Ferrandina
No relevant relationships to disclose
Enrico Breda
No relevant relationships to disclose
Viviana Murgia
No relevant relationships to disclose
Cosimo Sacco
No relevant relationships to disclose
Nuria Maria Asensio Sierra
No relevant relationships to disclose
Carmela Pisano
No relevant relationships to disclose
Vanda Salutari
No relevant relationships to disclose
Beatrice E. Weber
No relevant relationships to disclose
Eric Pujade-Lauraine
No relevant relationships to disclose
Ciro Gallo
No relevant relationships to disclose
Francesco Perrone
No relevant relationships to disclose